The recent activities of key executives at Itron, Inc., coupled with the company's latest quarterly performance and mixed analyst commentary, present a complex picture for investors tracking NASDAQ:ITRI.
In a reported transaction, Deitrich Thomas, President and CEO of Itron, sold 760 shares of the firm’s common stock on May 20, 2026. The total value realized from this sale was $60,494, with each share selling at $79.5976. This specific disposition was reportedly undertaken to satisfy tax withholding obligations related to the vesting of a restricted stock unit award.
Following the divestiture, Mr. Thomas's direct holdings in ITRON common stock decreased, leaving him with 369,541 shares. His indirect stake remains substantial, comprising an additional 25,000 shares held through a trust arrangement.
The market reaction to this news was notable. While the stock price has since climbed to $82.30, it continues to trade in proximity to its 52-week low of $77.77, suggesting underlying valuation concerns persist despite the CEO's actions and recent earnings.
Financial Performance and Analyst Adjustments
In separate news detailing corporate performance, Itron Inc. disclosed its financial results for the first quarter of 2026. These figures indicated a period of robust operational activity, as the company managed to surpass general market expectations across key metrics.
Specifically, Itron's revenue reached $587 million, which outperformed the anticipated figure of $572.09 million. Furthermore, the earnings per share (EPS) for the quarter was reported at $1.49, exceeding the projected EPS estimate of $1.23. These strong financial outcomes suggest significant operational execution by the company.
However, this positive performance did not prevent caution from some market analysts. Roth/MKM adjusted its price target for Itron, lowering it from a previous level of $150 down to $136. Despite making this downward adjustment, the firm maintained an overall 'Buy' rating on the shares. The rationale provided by Roth/MKM attributed this reduction in the price target to what they perceive as a more subdued near-term revenue growth trajectory.
Valuation Context and Market Insight
From an analytical standpoint, external data suggests that ITRON currently appears undervalued. According to InvestingPro analysis, the stock's Fair Value assessment indicates potential undervaluation. The company is trading with a current P/E ratio of 13.1 and commands a market capitalization estimated at $3.65 billion.
These varied developments - strong quarterly earnings juxtaposed against downward price target revisions and insider selling - highlight the complex environment in which Itron operates, navigating both positive financial results and careful analyst assessments regarding future growth rates.
Risks
- The primary risk highlighted is the 'more subdued near-term revenue growth trajectory,' which prompted Roth/MKM to lower its price target.
- Insider selling by the CEO for tax purposes occurred while the stock remained near its 52-week low of $77.77, suggesting potential lack of strong internal confidence at that time.
More from Insider Trading